IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.3510
+0.0324 (10.17%)
At close: Apr 22, 2026, 4:00 PM EDT
0.3500
-0.0010 (-0.28%)
After-hours: Apr 22, 2026, 8:00 PM EDT
IGC Pharma Employees
IGC Pharma had 70 employees as of March 31, 2025. The number of employees increased by 3 or 4.48% compared to the previous year.
Employees
70
Change (1Y)
3
Growth (1Y)
4.48%
Revenue / Employee
$15,800
Profits / Employee
-$92,086
Market Cap
33.63M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2025 | 70 | 3 | 4.48% | 70 | 0 |
| Mar 31, 2024 | 67 | 6 | 9.84% | 67 | 0 |
| Mar 31, 2023 | 61 | 9 | 17.31% | 61 | 0 |
| Mar 31, 2022 | 52 | 2 | 4.00% | 52 | 0 |
| Mar 31, 2021 | 50 | 0 | - | 50 | 0 |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Kyntra Bio | 34 |
| Jasper Therapeutics | 22 |
| ABVC BioPharma | 19 |
| Lantern Pharma | 16 |
| Apollomics | 13 |
| Tvardi Therapeutics | 12 |
| AEON Biopharma | 8 |
IGC News
- 13 hours ago - IGC Pharma Adds Kerwin Medical Center in Dallas to Phase 2 CALMA Trial as Enrollment Advances Toward Completion - Accesswire
- 2 days ago - IGC Pharma Secures Psilocybin Research Authorization, Expanding Focus on Neuropsychiatric Symptoms in Dementia - Accesswire
- 8 days ago - IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of Enrollment Completion and Data Readout - Accesswire
- 14 days ago - Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts - Accesswire
- 15 days ago - IGC Pharma Adds Tandem Clinical Research to the CALMA Trial for Agitation in Alzheimer's Disease - Accesswire
- 23 days ago - IGC Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness - Accesswire
- 4 weeks ago - IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025 - Accesswire
- 5 weeks ago - IGC Pharma to Showcase AI Platform with Alzheimer's Disease Data Initiative at ADPD 2026 - Accesswire